Endurant Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-14,300
Closed -$2.47M 117
2015
Q1
$2.47M Sell
14,300
-4,800
-25% -$705K 0.82% 45
2014
Q4
$2.19M Buy
+19,100
New +$2.31M 0.86% 40

Other funds holding SLXP

Endurant Capital Management's SLXP Position: Q2 2015 in Review

Endurant Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 14,300 shares — an estimated $2.47M sold.

Endurant Capital Management first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $2.47M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Endurant Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Endurant Capital Management sold 14,300 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.47M.
  • Endurant Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
  • Endurant Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.47M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Endurant Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.